Sulforaphane inhibits endothelial lipase expression through NF-κB in endothelial cells

Atherosclerosis

Volumn 213, Issue 1, 2010, Pages 122-128

  Kivelä, Annukka M ^a   Mäkinen, Petri I ^a   Jyrkkänen, Henna Kaisa ^a   Mella Aho, Eero ^a   Xia, Yifeng ^b   Kansanen, Emilia ^a   Leinonen, Hanna ^a   Verma, Inder M ^b   Ylä Herttuala, Seppo ^a   Levonen, Anna Liisa ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

Atherosclerosis; Endothelial lipase; High density lipoprotein; Nuclear factor (NF) B; Sulforaphane

Indexed keywords

CYTOKINE; ENDOTHELIAL LIPASE; HIGH DENSITY LIPOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; RNA; SULFORAPHANE; TRIACYLGLYCEROL LIPASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; DRUG TARGETING; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENETIC TRANSDUCTION; LENTIVIRINAE; LIPID METABOLISM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RNA INTERFERENCE; UMBILICAL VEIN; WESTERN BLOTTING;

ANTIOXIDANTS; ATHEROSCLEROSIS; CELLS, CULTURED; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; I-KAPPA B KINASE; ISOTHIOCYANATES; LIPASE; MODELS, BIOLOGICAL; NF-KAPPA B; PROTEIN BINDING; THIOCYANATES; UMBILICAL VEINS; VEGETABLES;

EID: 77958488608     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.07.015     Document Type: Article

References (31)

1. Gordon D.J., Rifkind B.M. High-density lipoprotein-the clinical implications of recent studies. N Engl J Med 1989, 321:1311-1316.
2. Rader D.J. Molecular regulation of HDL metabolism and function: implications for novel therapies. J Clin Invest 2006, 116:3090-3100.
3. Jaye M., Lynch K.J., Krawiec J., et al. A novel endothelial-derived lipase that modulates HDL metabolism. Nat Genet 1999, 21:424-428.
4. McCoy M.G., Sun G.S., Marchadier D., et al. Characterization of the lipolytic activity of endothelial lipase. J Lipid Res 2002, 43:921-929.
5. Ishida T., Choi S., Kundu R.K., et al. Endothelial lipase is a major determinant of HDL level. J Clin Invest 2003, 111:347-355.
6. Jin W., Millar J.S., Broedl U., et al. Inhibition of endothelial lipase causes increased HDL cholesterol levels in vivo. J Clin Invest 2003, 111:357-362.
7. Ma K., Cilingiroglu M., Otvos J.D., et al. Endothelial lipase is a major genetic determinant for high-density lipoprotein concentration, structure, and metabolism. Proc Natl Acad Sci U S A 2003, 100:2748-2753.
8. deLemos A.S., Wolfe M.L., Long C.J., et al. Identification of genetic variants in endothelial lipase in persons with elevated high-density lipoprotein cholesterol. Circulation 2002, 106:1321-1326.
9. Mank-Seymour A.R., Durham K.L., Thompson J.F., et al. Association between single-nucleotide polymorphisms in the endothelial lipase (LIPG) gene and high-density lipoprotein cholesterol levels. Biochim Biophys Acta 2004, 1636:40-46.
10. Edmondson A.C., Brown R.J., Kathiresan S., et al. Loss-of-function variants in endothelial lipase are a cause of elevated HDL cholesterol in humans. J Clin Invest 2009, 119:1042-1050.
11. Hirata K., Ishida T., Matsushita H., et al. Regulated expression of endothelial cell-derived lipase. Biochem Biophys Res Commun 2000, 272:90-93.
12. Badellino K.O., Wolfe M.L., Reilly M.P., et al. Endothelial lipase is increased in vivo by inflammation in humans. Circulation 2008, 117:678-685.
13. Jin W., Sun G.S., Marchadier D., et al. Endothelial cells secrete triglyceride lipase and phospholipase activities in response to cytokines as a result of endothelial lipase. Circ Res 2003, 92:644-650.
14. Kempe S., Kestler H., Lasar A., et al. NF-kappaB controls the global pro-inflammatory response in endothelial cells: evidence for the regulation of a pro-atherogenic program. Nucleic Acids Res 2005, 33:5308-5319.
15. Qiu G., Hill J.S. Atorvastatin decreases lipoprotein lipase and endothelial lipase expression in human THP-1 macrophages. J Lipid Res 2007, 48:2112-2122.
16. Li Q., Verma I.M. NF-kappaB regulation in the immune system. Nat Rev Immunol 2002, 2:725-734.
17. Bertl E., Bartsch H., Gerhauser C. Inhibition of angiogenesis and endothelial cell functions are novel sulforaphane-mediated mechanisms in chemoprevention. Mol Cancer Ther 2006, 5:575-585.
18. Schwab M., Reynders V., Loitsch S., et al. The dietary histone deacetylase inhibitor sulforaphane induces human beta-defensin-2 in intestinal epithelial cells. Immunology 2008, 125:241-251.
19. Thejass P., Kuttan G. Immunomodulatory activity of sulforaphane, a naturally occurring isothiocyanate from broccoli (Brassica oleracea). Phytomedicine 2007, 14:538-545.
20. Heiss E., Herhaus C., Klimo K., et al. Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms. J Biol Chem 2001, 276:32008-32015.
21. Xu C., Shen G., Chen C., et al. Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells. Oncogene 2005, 24:4486-4495.
22. Mäkinen P.I., Koponen J.K., Kärkkäinen A.M., et al. Stable RNA interference: comparison of U6 and H1 promoters in endothelial cells and in mouse brain. J Gene Med 2006, 8:433-441.
23. Kivela A.M., Kansanen E., Jyrkkanen H.K., et al. Enterolactone induces heme oxygenase-1 expression through nuclear factor-E2-related factor 2 activation in endothelial cells. J Nutr 2008, 138:1263-1268.
24. Van Antwerp D.J., Martin S.J., Kafri T., et al. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 1996, 274:787-789.
25. Tiscornia G., Tergaonkar V., Galimi F., et al. CRE recombinase-inducible RNA interference mediated by lentiviral vectors. Proc Natl Acad Sci U S A 2004, 101:7347-7351.
26. Riedl M.A., Saxon A., Diaz-Sanchez D. Oral sulforaphane increases phase II antioxidant enzymes in the human upper airway. Clin Immunol 2009, 130:244-251.
27. Hu R., Hebbar V., Kim B.R., et al. In vivo pharmacokinetics and regulation of gene expression profiles by isothiocyanate sulforaphane in the rat. J Pharmacol Exp Ther 2004, 310:263-271.
28. Broedl U.C., Jin W., Rader D.J. Endothelial lipase: a modulator of lipoprotein metabolism upregulated by inflammation. Trends Cardiovasc Med 2004, 14:202-206.
29. Luedde T., Heinrichsdorff J., de Lorenzi R., et al. IKK1 and IKK2 cooperate to maintain bile duct integrity in the liver. Proc Natl Acad Sci U S A 2008, 105:9733-9738.
30. Schindler U., Baichwal V.R. Three NF-kappa B binding sites in the human E-selectin gene required for maximal tumor necrosis factor alpha-induced expression. Mol Cell Biol 1994, 14:5820-5831.
31. Liu Y.C., Hsieh C.W., Weng Y.C., et al. Sulforaphane inhibition of monocyte adhesion via the suppression of ICAM-1 and NF-kappaB is dependent upon glutathione depletion in endothelial cells. Vasc Pharmacol 2008, 48:54-61.